Phillips, KENYA
 - Mobilization Mission
 - Training Beneficiaries
 - Photo-Journal

RWANDA
 - Photo-Journal
 - Decentralization Timeline
 - Access Conditions

ANADER, RCI
 - Partnership Info.
 - Project Map
 - Risk Map
 - Care Project
 - Revenue Model
 - Villagers Testimonials
 - Real Life Story

 
Management of individual patients leading to HIV workplace programs
 

- HIV Team in France
- HIV Team in Africa

Issue 5, August 2005   
 

Welcome to the fifth issue of. , the monthly newsletter from the MSD Interpharma HIV Team.

 


HIV@MSD is the monthly newsletter from the MSD Interpharma HIV Team who provides support for the development and implementation of comprehensive HIV/AIDS strategies that are conducted in partnership with many different national programs, with private sector entrepreneurs, and with bilateral organizations. Through our newsletter, we would like to share with you the lessons we have learned from these projects and activities.

This month: KENYA - HIV@MSD takes you in the footsteps of Mr. Mukesh Mehta, Managing Director of Phillips Pharmaceuticals, an enthusiastic supporter of the motto "you can do it if you really try!"

Not content with asking his staff to walk barefooted on burning ashes to show them that "they can do it", this strange entrepreneur is demonstrating the same negotiation and persuasion skills when it comes to improving the life of thousands of HIV-infected people living in his country.

 
  • Contribute to the implementation of the Accelerating Access Initiative in Kenya,
  • Sell his antiretroviral drugs with no profit to allow a larger number of patients to access optimal therapy,
  • Offer the dedication and technical knowledge of his HIV team to the private sector in order to initiate HIV/AIDS workplace programs,
  • Lobby against any decision that could harm East African patients' life: E.g, the 10% duty tax applied on imported drugs early this year, that would have led to a reduction in patients under treatment at a time when international funds were disbursed to help increase this very number of patients. On 12 April'05, the Kenya Revenue Authority announced the suspension of this tax for ARV's and all other drugs and medicaments, until further notice.

This is a summary of various solidarity measures to his credit.

"Each company needs to define its social responsibility and work towards reaching that objective" he says.....................Find out more!




 

Our mailing list has been registered with the the French Data Protection Authority. It contains your first name, family name and email address which shall be used only to send you this newsletter. In accordance with articles 38 and seq. of the French Data Privacy Law dated January 6, 1978 as amended, you may access, modify or delete your personal information upon request. Read our PRIVACY NOTICE for more information.

To remove your address from our mailing list, please UNSUBSCRIBE